Choosing the Right Treatment for Tardive Dyskinesia

Formulate an approach to select the right treatment for patients with tardive dyskinesia.
Manish Kumar Jha, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.70 MB
Released: June 17, 2021


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences

Related Content

Clinical Care Options (CCO) commentary by Jonathan M. Meyer, MD, on VMAT2 inhibitors in TD and anticholinergic exacerbation of TD symptoms.

Jonathan M. Meyer, MD Released: July 8, 2021

Slides from a presentation that formulates an approach to diagnose patients with tardive dyskinesia.

Greg Mattingly, MD Released: June 21, 2021

Clinical Care Options (CCO) commentary by Rifaat S. El-Mallakh, MD, on the differential diagnosis of tardive dyskinesia

Rif S. El-Mallakh, MD Released: June 8, 2021

Tardive Dyskinesia and Affective Disorders Nuances in the 21st Century: a free Clinical Care Options (CCO) on-demand webcast tailored to practicing healthcare professionals.

Sanjay Gupta, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit Psychologists: 1.0 APA CE Credit Released: February 22, 2021 Expired: February 22, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.